ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $299,000 | -6.3% | 9,050 | 0.0% | 0.08% | -8.9% |
| Q2 2022 | $319,000 | -23.3% | 9,050 | 0.0% | 0.09% | -2.2% |
| Q1 2022 | $416,000 | -30.7% | 9,050 | 0.0% | 0.09% | -30.8% |
| Q4 2021 | $600,000 | +6.2% | 9,050 | 0.0% | 0.13% | -8.3% |
| Q3 2021 | $565,000 | -24.7% | 9,050 | 0.0% | 0.14% | -20.8% |
| Q2 2021 | $750,000 | +25.0% | 9,050 | 0.0% | 0.18% | +19.6% |
| Q1 2021 | $600,000 | -13.5% | 9,050 | 0.0% | 0.15% | -18.2% |
| Q4 2020 | $694,000 | +77.9% | 9,050 | 0.0% | 0.19% | +49.6% |
| Q3 2020 | $390,000 | -0.3% | 9,050 | 0.0% | 0.12% | -11.3% |
| Q2 2020 | $391,000 | +41.7% | 9,050 | -5.6% | 0.14% | +20.5% |
| Q1 2020 | $276,000 | -51.1% | 9,585 | +7.9% | 0.12% | -44.3% |
| Q4 2019 | $564,000 | +125.6% | 8,885 | 0.0% | 0.21% | +105.9% |
| Q3 2019 | $250,000 | +6.4% | 8,885 | 0.0% | 0.10% | +5.2% |
| Q2 2019 | $235,000 | – | 8,885 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |